1. A new Kunitz‐type snake toxin family associated with an original mode of interaction with the vasopressin 2 receptor. (28th February 2022) Authors: Droctové, Laura; Ciolek, Justyna; Mendre, Christiane; Chorfa, Amélia; Huerta, Paola; Carvalho, Chrystelle; Gouin, Charlotte; Lancien, Manon; Stanajic‐Petrovic, Goran; Braco, Lorine; Blanchet, Guillaume; Upert, Gregory; De Pauw, Gregory; Barbe, Peggy; Keck, Mathilde; Mourier, Gilles; Mouillac, Ber... Other Names: Lother Achim guestEditor.; Wenzel Ulrich guestEditor.; Jaisser Frédéric guestEditor. Journal: British journal of pharmacology Issue: Volume 179:Number 13(2022) Page Start: 3470 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysis of CLCNKB mutations at dimer‐interface, calcium‐binding site, and pore reveals a variety of functional alterations in ClC‐Kb channel leading to Bartter syndrome. Issue 4 (24th December 2019) Authors: Bignon, Yohan; Sakhi, Imene; Bitam, Sara; Bakouh, Naziha; Keck, Mathilde; Frachon, Nadia; Paulais, Marc; Planelles, Gabrielle; Teulon, Jacques; Andrini, Olga Journal: Human mutation Issue: Volume 41:Issue 4(2020) Page Start: 774 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice. (February 2019) Authors: Boitard, Solène Emmanuelle; Marc, Yannick; Keck, Mathilde; Mougenot, Nathalie; Agbulut, Onnik; Balavoine, Fabrice; Llorens-Cortes, Catherine Journal: Journal of molecular and cellular cardiology Issue: Volume 127(2019) Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. BRAIN-PENETRATING AMINOPEPTIDASE A INHIBITORS FOR NEW TREATMENT OF HYPERTENSION AND HEART FAILURE. (April 2021) Authors: Llorens-Cortes, Catherine; Hmazzou, Reda; Boitard, Solene; Marc, Yannick; Keck, Mathilde; Balavoine, Fabrice; Roques, Bernard Journal: Journal of hypertension Issue: Volume 39(2021)e-Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Emergence of Orai3 activity during cardiac hypertrophy. (11th September 2014) Authors: Saliba, Youakim; Keck, Mathilde; Marchand, Alexandre; Atassi, Fabrice; Ouillé, Aude; Cazorla, Olivier; Trebak, Mohamed; Pavoine, Catherine; Lacampagne, Alain; Hulot, Jean-Sébastien; Farès, Nassim; Fauconnier, Jérémy; Lompré, Anne-Marie Journal: Cardiovascular research Issue: Volume 105:Number 3(2015) Page Start: 248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. NI956/QGC006, a Potent Orally Active, Brain-Penetrating Aminopeptidase A Inhibitor for Treating Hypertension. Issue 6 (June 2019) Authors: Keck, Mathilde; De Almeida, Hugo; Compère, Delphine; Inguimbert, Nicolas; Flahault, Adrien; Balavoine, Fabrice; Roques, Bernard; Llorens-Cortes, Catherine Journal: Hypertension Issue: Volume 73:Issue 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Novel CLCNKB Mutations Causing Bartter Syndrome Affect Channel Surface Expression. Issue 9 (12th June 2013) Authors: Keck, Mathilde; Andrini, Olga; Lahuna, Olivier; Burgos, Johanna; Cid, L. Pablo; Sepúlveda, Francisco V.; L'Hoste, Sébastien; Blanchard, Anne; Vargas‐Poussou, Rosa; Lourdel, Stéphane; Teulon, Jacques Journal: Human mutation Issue: Volume 34:Issue 9(2013:Sep.) Page Start: 1269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗